| Whitefield Industrials Limited (WHF) ORDINARY FULLY PAID |
Financials |
$655 |
Net Tangible Asset Backing - Dec 25
|
14 Jan 2026 9:15AM |
$5.410 |
$5.420 |
risen by
0.18%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$13 |
Notification regarding unquoted securities - ENL
|
14 Jan 2026 9:14AM |
$0.019 |
$0.016 |
fallen by
15.79%
|
|
| Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$6 |
High Grade Silver and Antimony Results
|
14 Jan 2026 9:14AM |
$0.025 |
$0.026 |
risen by
4%
|
|
DBO - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver, antimony, and copper systems confirmed at Star Range Project.
- New prospect areas identified: East Star, West Star, and Silver Gulch.
- North Star Prospect is a priority drill target with significant mineralisation.
- Peak assay results include 880 g/t Ag, 9.3 g/t Au, 0.6% Sb, and 2.6% Cu.
- Project located in Utah, USA, with excellent infrastructure and nearby historical mines.
- Drill targeting is well advanced, with geophysical data integration ongoing.
- Exploration efforts focus on extending mineralised trends and defining new targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,337 |
Update - Notification of buy-back - FLT
|
14 Jan 2026 9:12AM |
$15.030 |
$15.690 |
risen by
4.39%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$38 |
Update - Notification of buy-back - MEC
|
14 Jan 2026 9:10AM |
$1.185 |
$1.200 |
risen by
1.27%
|
|
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$243 |
Widespread gold identified at Nyungu Central
|
14 Jan 2026 9:09AM |
$0.345 |
$0.345 |
fallen by
0%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- 32 holes drilled, 26 with significant gold grades.
- 30m at 0.21g/t Au from 187m, within 30m at 0.79% Cu.
- Maiden gold resource estimate in development.
- Potential economic upgrade for the Mumbezhi Project.
- Further assay results expected by January 2026.
- MRE updates scheduled for late Q1 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$999 |
Weekly Net Tangible Asset Backing
|
14 Jan 2026 9:09AM |
$1.765 |
$1.825 |
risen by
3.40%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$24 |
Trading Halt
|
14 Jan 2026 9:09AM |
$0.054 |
$0.074 |
risen by
37.04%
|
|
DAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Dalaroo Metals Ltd.
- Pending announcement of exploration results from Blue Lagoon Project in Greenland.
- Trading halt effective from 14 January 2026.
- Halt to end on 16 January 2026 or upon release of the announcement.
- No known reasons against granting the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$50 |
Notification of cessation of securities - RIM
|
14 Jan 2026 9:09AM |
$0.017 |
$0.018 |
risen by
5.88%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
SPH Notice - China Resources Asset Management Limited
|
14 Jan 2026 9:08AM |
$0.180 |
$0.180 |
fallen by
0%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
SPH Notice - China Resources Enterprise, Limited
|
14 Jan 2026 9:07AM |
$0.180 |
$0.180 |
fallen by
0%
|
|
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$540 |
PDI: Court Approves Robex Plan of Arrangement
|
14 Jan 2026 9:05AM |
$6.890 |
$6.540 |
fallen by
5.08%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex Resources Inc. received court approval for the plan of arrangement.
- Predictive Discovery Limited to acquire all Robex shares.
- Arrangement approved by Robex shareholders on 30 December 2025.
- Transaction completion pending regulatory consents from Guinea and Mali.
- Expected transaction closure in Q1 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,075 |
Court Approves Robex Plan of Arrangement
|
14 Jan 2026 9:05AM |
$0.885 |
$0.790 |
fallen by
10.73%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Predictive Discovery Limited (PDI) announced that Robex Resources Inc. received court approval for a plan of arrangement.
- PDI, through its subsidiary, will acquire all common shares of Robex.
- The arrangement was approved by Robex shareholders prior to the court decision.
- Closing of the transaction requires additional approvals from the Governments of Guinea and Mali.
- The transaction is expected to close in Q1 2026.
- This announcement was authorized by the PDI Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$67 |
MX1 - Notice Under Section 708A(5) of the Corporations Act
|
14 Jan 2026 9:05AM |
$0.086 |
$0.092 |
risen by
6.98%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$544 |
Racura Oncology Emory University Collaboration
|
14 Jan 2026 9:04AM |
$2.880 |
$3.010 |
risen by
4.51%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Racura Oncology Ltd has commenced a collaboration with Emory University to study (E,E)-bisantrene in osimertinib-resistant EGFR-mutated NSCLC.
- The collaboration is led by Professor Shi-Yong Sun, a world-leader in osimertinib-resistant lung cancer biology.
- Racura has access to Emory’s unique osimertinib-resistant cell and mouse NSCLC models and expertise.
- The program supports the HARNESS-1 clinical trial of (E,E)-bisantrene aimed at delaying or preventing resistance to osimertinib.
- The collaboration seeks to characterise the biology and mechanisms of resistance in EGFRm NSCLC.
- Racura Oncology is aiming to extend progression-free and overall survival in patients by targeting osimertinib-resistant sub-clones.
- Professor Sun’s expertise is pivotal in understanding the biology of impressive efficacy when combining (E,E)-bisantrene with osimertinib.
- The collaboration is expected to produce high-quality, mechanism-informed preclinical data supporting RC220.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$231 |
Final Director's Interest Notice
|
14 Jan 2026 9:04AM |
$3.010 |
$2.840 |
fallen by
5.65%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$203 |
December 2025 Investment Update
|
14 Jan 2026 9:02AM |
$1.030 |
$1.030 |
fallen by
0%
|
|
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,075 |
RXR: Robex Obtains Final Court Approval for Plan of Arrangem
|
14 Jan 2026 9:01AM |
$0.885 |
$0.790 |
fallen by
10.73%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex obtained final court approval for the merger with Predictive Discovery Ltd.
- The merger involves acquiring all issued shares of Robex by Predictive's subsidiary.
- The transaction was approved by Robex shareholders on 30 December 2025.
- Completion expected in Q1 2026, subject to government consents and conditions.
- Robex's key projects are in Mali and Guinea.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$540 |
Robex Obtains Final Court Approval for Plan of Arrangement
|
14 Jan 2026 9:01AM |
$6.890 |
$6.540 |
fallen by
5.08%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex Resources Inc. merger agreement with Predictive Discovery Limited approved.
- Final court approval received from Québec Superior Court.
- Merger involves acquisition of all Robex shares by Predictive's subsidiary.
- Arrangement approved at Robex's shareholder meeting on December 30, 2025.
- Completion expected in Q1 2026, subject to government consents and other conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ion Video Ltd (IOV) ORDINARY FULLY PAID |
Information Technology |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
14 Jan 2026 9:01AM |
$0.002 |
$0.003 |
risen by
25%
|
|
IOV - Price-sensitive ASX Announcement
Full Release
Key Points
- ION Video brand unveiling scheduled for February 2026.
- Restructuring led by major security holders Brent Jones and Anthony Baker.
- Capital raise of $2.95 million, with $1.2 million from directors.
- Significant reduction of trade creditors and payables from $2.2 million to $280k.
- Focus on aligning technology with core patents.
- Estimated cash sufficient until Q2 2027.
- Reduction in recurring engineering and third-party costs by $1.8 million.
- Planned technology demonstration in February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| State Gas Limited (GAS) ORDINARY FULLY PAID |
Energy |
$10 |
Waiver of ASX Listing Rule 10.1 Granted
|
14 Jan 2026 9:01AM |
$0.026 |
$0.026 |
fallen by
0%
|
|
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$67 |
Application for quotation of securities - MX1
|
14 Jan 2026 9:00AM |
$0.086 |
$0.092 |
risen by
6.98%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$768 |
Update - Notification of buy-back - RF1
|
14 Jan 2026 9:00AM |
$3.480 |
$3.650 |
risen by
4.89%
|
|
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$17 |
HIGH GRADE ASSAYS UP TO 1.3% WO3 FROM LINKA TUNGSTEN PROJECT
|
14 Jan 2026 8:59AM |
$0.008 |
$0.010 |
risen by
25%
|
|
VKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viking Mines Limited has reported high-grade assay results up to 1.3% WO3 from the Linka Tungsten Project in Nevada, USA.
- Four metallurgical samples totaling 295kg were collected, with the Linka Open Pit sample showing the highest concentration of 1.3% WO3.
- The average grade across these samples is 1.0% WO3, confirming the high-grade nature of the mineralization.
- Metallurgical testwork is underway to establish a process flowsheet for producing a scheelite concentrate.
- The company plans further geological and metallurgical studies, including high-resolution aerial surveys and geophysical surveys.
- Viking Mines is in the process of acquiring the Linka Project along with five other tungsten projects in the USA.
- Global scheelite concentrate prices are at an all-time high, making the project's economic potential significant.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$67 |
Application for quotation of securities - MX1
|
14 Jan 2026 8:59AM |
$0.086 |
$0.092 |
risen by
6.98%
|
|